Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Subfertility
Interventions
DRUG

Testosterone

10 mg of testosterone gel applied on the external side of the thigh for 21 days starting from the first day of menstruation prior to initiation of ovarian stimulation with rFSH for IVF/ICSI

Trial Locations (1)

Unknown

Unit for Human Reproduction, 1st Dept of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

collaborator

University of Thessaly

OTHER

NCT01961336 - Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF | Biotech Hunter | Biotech Hunter